Literature DB >> 23053190

Operative treatment of scoliosis in proximal spinal muscular atrophy: results of 41 patients.

Albert Fujak1, Wolfgang Raab, Alexander Schuh, Alexander Kreß, Raimund Forst, Jürgen Forst.   

Abstract

INTRODUCTION: The early development of progressive scoliosis with pelvic obliquity is the most significant orthopaedic problem for non-ambulatory children with spinal muscular atrophy (SMA). PATIENTS: 24 SMA patients were operated on for scoliosis using the ISOLA(®) system and 17 patients using a telescopic rod. The average age at spinal surgery was 12.3 years (6.5-22.7) in the ISOLA(®) group and 6.7 years (4.8-10.9) in the telescopic rod group.
RESULTS: The Cobb angle was corrected on average from pre-operative 83°(54°-120°) to post-operative 39°(5°-70°) in the ISOLA(®) group and, respectively, from 62°(28°-86°) to 18°(0°-34°) in the telescopic rod group. Mean loss of correction at mean follow-up of 6 years (3-10) was 6°(0°-33°) in the ISOLA(®) group and at mean follow-up of 8.6 years (3-12) 13°(0°-49°) in the telescopic rod group excluding the patients with rod failure. The vital capacity is not worsened by these operations in comparison to the natural course. After telescopic rods were implanted, there were some unsatisfactory results due to crankshaft phenomenon and an increase of pelvic obliquity.
CONCLUSION: Our recommendation for non-ambulatory SMA patients is to have definitive stabilisation using multisegmental instrumentation, starting from the age of 10 to 12 years.

Entities:  

Mesh:

Year:  2012        PMID: 23053190     DOI: 10.1007/s00402-012-1610-8

Source DB:  PubMed          Journal:  Arch Orthop Trauma Surg        ISSN: 0936-8051            Impact factor:   3.067


  8 in total

1.  The effect of scoliosis surgery on pulmonary function in spinal muscular atrophy type II patients.

Authors:  Shih-Hsiang Chou; Gau-Tyan Lin; Po-Chih Shen; Yi-Jing Lue; Cheng-Chang Lu; Yin-Chun Tien; Yen-Mou Lu
Journal:  Eur Spine J       Date:  2016-11-02       Impact factor: 3.134

Review 2.  Spinal muscular atrophy: diagnosis and management in a new therapeutic era.

Authors:  W David Arnold; Darine Kassar; John T Kissel
Journal:  Muscle Nerve       Date:  2014-12-16       Impact factor: 3.217

Review 3.  The effect of scoliosis surgery on pulmonary function in spinal muscular atrophy patients: review of the literature and a meta-analysis.

Authors:  Maria Angeli; Kalliopi Alpantaki; Nikolaos Pandis; Christos Koutserimpas; Alexander Hadjipavlou
Journal:  Eur Spine J       Date:  2022-06-04       Impact factor: 2.721

4.  Safety and Efficacy of Treatment for Scolios Is Secondary to Spinal Muscular Atrophy Fused to Lumbar 5 Level.

Authors:  Shoichiro Takei; Masayuki Miyagi; Wataru Saito; Takayuki Imura; Gen Inoue; Toshiyuki Nakazawa; Eiki Shirasawa; Kentaro Uchida; Tsutomu Akazawa; Naonobu Takahira; Masashi Takaso
Journal:  Spine Surg Relat Res       Date:  2018-04-27

Review 5.  Proximal spinal muscular atrophy: current orthopedic perspective.

Authors:  Gerrit Haaker; Albert Fujak
Journal:  Appl Clin Genet       Date:  2013-11-14

6.  Cervical rotation, chest deformity and pelvic obliquity in patients with spinal muscular atrophy.

Authors:  Agnieszka Stępień; Łucja Mazurkiewicz; Katarzyna Maślanko; Witold Rekowski; Maria Jędrzejowska
Journal:  BMC Musculoskelet Disord       Date:  2020-11-07       Impact factor: 2.362

7.  Natural course of scoliosis in proximal spinal muscular atrophy type II and IIIa: descriptive clinical study with retrospective data collection of 126 patients.

Authors:  Albert Fujak; Wolfgang Raab; Alexander Schuh; Silvia Richter; Raimund Forst; Jürgen Forst
Journal:  BMC Musculoskelet Disord       Date:  2013-10-04       Impact factor: 2.362

8.  Predictors for Deformity Progression in a Spinal Muscular Atrophy Cohort After Scoliosis Correction Surgery.

Authors:  Po-Chih Shen; Cheng-Chang Lu; Wen-Chen Liang; Yin-Chun Tien; Yuh-Jyh Jong; Yen-Mou Lu; Zi-Miao Liu; Chia-Lung Shih; Shih-Hsiang Chou
Journal:  Clin Spine Surg       Date:  2020-10       Impact factor: 1.723

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.